Bruker Corp (BRKR)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$32.15
Buy
$37.88
$0.68 (+1.88%)
Prices updated at 03 Apr 2026, 00:22 EDT
| Prices minimum 15 mins delay
Prices in USD
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Dr. Frank H. Laukien,PhD
CEO
Dr. Frank H. Laukien,PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
11,085
Head office
40 Manning Road
Billerica
United States
01821
Key personnel
Owner name | Salary |
|---|---|
Dr. Cynthia M. Friend, PhD Independent Director | 0.09m |
Mr. Thierry L. Bernard Director | - |
Dr. Frank H. Laukien,PhD Chairman of the Board, President and Chief Executive Officer | 0.97m |
Mr. John A. Ornell Independent Director | 0.11m |
Mr. Richard A. Packer Independent Director | 0.09m |
Dr. William A. Linton Lead Independent Director | 0.10m |
Ms. Adelene Q. Perkins Independent Director | 0.09m |
Mr. Gerald N. Herman Executive Vice President and Chief Financial Officer | 0.64m |
Dr. Hermann F. Requardt, PhD Independent Director | 0.09m |
Ms. Laura A. Francis Independent Director | - |
Dr. Robert J. Rosenthal, PhD Independent Director | 0.09m |
Ms. Bonnie H. Anderson Independent Director | 0.09m |
Mr. John J. Phillips Director | - |
Mr. Thomas M. Bures Chief Accounting Officer | - |
Dr. Mark R. Munch,PhD Executive Vice President; President of Bruker Nano Group and Bruker Nano Surfaces Division | 0.73m |
Mr. Burkhard Prause President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc | - |
Mr. Juergen Srega President, Bruker CALID Group and Bruker Daltonics Division | 0.48m |
Mr. Falko Busse President, Bruker BioSpin Group | 0.50m |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| FMR Inc | 15,229,626 |
| Fidelity Management and Research Company | 15,229,626 |
| Orbis Allan Gray Ltd | 14,906,730 |
| BlackRock Inc | 10,957,212 |
| Vanguard Group Inc | 10,259,824 |
Director dealings
Date | Action |
|---|---|
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 06 Nov 2025 | - |
| 06 Nov 2025 | - |
| 06 Nov 2025 | - |
| 12 Sep 2025 | - |
| 12 Sep 2025 | - |
| 12 Sep 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 15 Aug 2025 | - |
| 10 Aug 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
